TLGT News and Press, Teligent Inc. From 04/22/19

BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the response to the Complete Response Letter (“CRL”) it receive...

NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teligent, Inc. ("Teligent" or the "Company") (NASDAQ:TLGT) of the June 14, 2019 deadline to seek the role of lead plaintiff in a federal securities class actio...

In a statement , Teligent ( TLGT +3.4% ) CEO Jason Grenfell-Gardner says that his team is "not aware" of any fundamental changes to the business that would explain the recent softness in the stock. Shares have sold off  23%  since touching $1.30 on April 4. More news on: Telig...

BUENA, N.J., April 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today provided commentary on the recent market movements in the price of its stock. “Teligent acknowledges that there have been significant ne...

BUENA, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FD...

Motif Bio plc (NASDAQ: MTFB ) +55%  on iclaprim meeting with FDA. More news on: Motif Bio plc, China Bat Group, Inc., Nevro Corp., Stocks on the move, Read more ...

BUENA, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FD...

Teligent, Inc. (TLGT) Q4 2018 Earnings Conference Call March 18, 2019 08:00 AM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Elliot Wilbur - Raymond James Presentation...

Aerpio Pharmaceuticals (NASDAQ: ARPO )  -64%  after lead candidate flunks mid-stage study. More news on: Aerpio Pharmaceuticals, Inc., NII Holdings, Inc., PolarityTE, Inc., Stocks on the move, Read more ...

Teligent ( TLGT ) Q4 results : Revenues: $16.8M (+13.5%). More news on: Teligent, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...